XLV ETF Analysis: Health Care Sector Fund | NYSE
Health | NYSE, USA | Market Cap: 41.664m USD | 12M Return: 22.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 1.58B
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The Health Care Select Sector SPDR Fund (XLV) is an exchange-traded fund that seeks to track the performance of the Health Care Select Sector Index using a full replication strategy, investing at least 95% of its total assets in the underlying index securities. The index spans six healthcare-related industries, including pharmaceuticals, biotechnology, medical equipment, healthcare providers, life sciences tools, and health care technology. The fund is classified as non-diversified, meaning it may concentrate holdings in fewer issuers than a diversified fund.
As a sector-specific ETF, XLV provides investors with targeted exposure to the healthcare industry, which is generally considered a defensive sector due to the relatively inelastic demand for medical products and services regardless of economic conditions. The fund launched in December 1998 and is structured as a large-cap ETF, reflecting the dominance of major pharmaceutical and healthcare equipment companies in the underlying index.
- GLP-1 obesity drug sales drive pharma revenue growth
- Medicare drug price negotiations pressure pharma margins
- Hospital labor costs squeeze healthcare provider margins
As of July 28, 2026, the stock is trading at USD 163.40 with a total of 7,869,358 shares traded. Over the past week, the price has changed by +2.61%, over one month by +1.65%, over three months by +14.40% and over the past year by +22.88%.
Current recommended Stop Loss: 160.20 (which is 2% or 1.2 ATR below the current price).
Health Care Sector Fund has no consensus analysts rating.